baber/WOPTO huggingface dataset:
Patent CN-100452638-C (CN)
Title: 带调控装置的发电机静止可控硅励磁调节器
Inventor: SHUJIA WANG
IPC: H02P9/02
Filed: 2006-12-29
Granted: 2009-01-14
Abstract: 本发明涉及一种带调控装置的发电机静止可控硅励磁调节器，其包括柜体、设于柜体上的按钮和控制电路，控制电路中的八个开入继电器UM和24V电源设于柜体前部内面上，使DC24V电源远离强电的干扰。AC380V电源设于柜体后门板上，做到柜体的后部布置强电信号，柜体的前部布置弱电信号，形成强弱电信号各自独立的布线结构。经过此种布线结构后，该型号励磁调节器再也没发生过以上误动作。本发明具有结构简单、操作方便、抗干扰能力强等优点。
Patent CN-100557692-C (CN)
Inventor: KAZUNORI HASEGAWA
IPC: G11B17/26
Filed: 2006-01-18
Granted: 2009-11-04
Abstract: 一种可抑制处于待命状态的盘移动的盘装置。此盘装置通过垂直移动盘(12)在预期盘(12)下方提供工作空间(S)，且在转臂(30)位于规定位置后，把预期盘(12)放置在该转臂(30)上并执行记录再现。此时，预期盘(12)下方的待命盘(12A)位于工作空间(S)的下部且通过把盘固定部(70)的加压件(71)压向外周面来固定该待命盘(12A)。
Patent CN-100548429-C (CN)
Title: 一种过滤器
Inventor: NINGLAN WU
IPC: B01D24/10
Filed: 2007-04-20
Granted: 2009-10-14
Abstract: 一种过滤器，属净水与回收装置，包括壳体、壳体从下至上依次由集泥区、絮凝区、沉降区、过滤区、清水区水连通构成，集泥区为一锥形集泥斗，锥形集泥斗顶端置有一法兰帽，所述的法兰帽两侧的锥形集泥斗端口留有与絮凝区连通的泥水入口，法兰帽顶部开孔连通一进气管；一中心进液罐上部连接进水管，顶部连接排气管，底部固定在法兰帽中央，其与法兰帽连接处的侧壁上开有出水孔，本设备是一种集沉降、过滤、排浆、清洗等集一体的多功能固液分离装置，运行中集泥好，出水平稳，过滤器效率高、寿命长、连续运转时间长、投资小、处理效果好、运行费用低，还可连续低压力运行，定时排放浓缩液，操作管理十分方便。
Patent CN-100532290-C (CN)
Inventor: YONGYOU HU
IPC: C02F9/04
Filed: 2007-11-30
Granted: 2009-08-26
Abstract: 本发明公开了一种在应急条件下处理突发性汞污染源水的方法。本发明采用硫化钠沉淀与强化混凝结合的方法，先用碱调节剂将pH值至9～11，依次加入Hg 2+ 和硫化物搅拌均匀，汞离子和硫化物的质量配比为2∶3～5，再加入无机混凝剂和有机高分子絮凝剂进行强化混凝处理，在无机混凝剂的投加量为30～50mg/L，有机高分子絮凝剂的投加量为0.05～0.2mg/L。该方法在汞超国家标准100倍以下，过滤出水可达标，在汞超国家标准60倍以下，沉淀出水可达标。
Patent CN-100595873-C (CN)
Inventor: QINHAN JIN
IPC: H01J49/10
Filed: 2007-02-07
Granted: 2010-03-24
Abstract: 本发明的双离子源矩形离子阱质谱仪属于科学仪器技术领域。矩形离子阱的电场是由x电极(1)、y电极(2)和z电极(3)三对电极围成的长方体区域，长方体两侧面的x电极(1)上开有矩形孔(4)，两端盖的z电极(3)的中央开有圆孔(5)，在矩形离子阱质量分析器的两端盖外各安装一个离子源(8)，从端盖的圆孔(5)注入离子；或当采用内电离的电子轰击离子源(9)时，内电离灯丝的电子从侧面的矩形孔(4)注入，另一离子源(8)从端盖的圆孔(5)注入离子。本发明不仅拓展了单台质谱仪的应用领域，最大化了其硬件设备的利用率，提高了性价比；而且还可以利用其独有的硬件结构对分子离子反应机理进行深入的研究。
Patent CN-100491523-C (CN)
Inventor: ZHENDONG LEI
IPC: A61K35/747
Filed: 2007-03-22
Granted: 2009-05-27
Abstract: 本发明提供两种乳杆菌株，德氏乳杆菌保加利亚亚种CGMCC No.1936和嗜酸乳杆菌CGMCC No.1937，以及将它们用于制备通便生态口服液的方法。该方法包括如下步骤：(1)采用MRS培养基对两种菌株分别进行培养，培养温度35℃，培养时间120h；(2)将步骤(1)中培养好的两种菌种按体积比1∶1接入菌种罐内进行复合培养，采用营养琼脂作为培养基，培养温度35℃，时间48h；(3)将步骤(2)中培养好的复合菌种接入大罐内做进一步培养，采用红糖作为培养基，培养温度28℃，时间72h；(4)将步骤(3)中所得液体按常规罐装制得产品。本发明所制通便生态口服液营养高、口味佳，产品质量稳定，保质期长。
Patent CN-100573235-C (CN)
Title: 多焦眼镜片
Inventor: MICHAEL SKINNER
IPC: G02C7/04
Filed: 2002-07-29
Granted: 2009-12-23
Abstract: 本发明提供可用于校正远视的镜片的设计方法，体现这种设计的镜片以及制造这些镜片的方法。本发明的镜片在多焦区域中显示出更好的远视光焦度和近视光焦度的分布，以及因此显示出改进的视敏度和佩戴者满意度。
Patent CN-100538282-C (CN)
Title: 一种电涡流传感器的数字化动态标定系统
Inventor: GANG LIU
IPC: G01D18/00
Filed: 2007-08-06
Granted: 2009-09-09
Abstract: 一种电涡流传感器数字化动态标定系统，用以对电涡流传感器进行动态标定。此系统主要由高速电机、磁轴承系统、动态标定盘、A/D转换芯片、FPGA芯片、USB总线及上位机组成。磁轴承系统配合高速电机带动动态标定盘高速旋转，产生输入给待测传感器的高频激励信号。光电传感器感应动态标定盘上的基准位置生成一个基准脉冲信号用于触发FPGA芯片控制的A/D转换芯片对传感器的输出信号进行数据采样，传感器输出信号经A/D转换芯片进行模数转换后送入FPGA芯片进行数据采集和处理，通过USB总线传入上位机，最终得到电涡流传感器的动态频率特性指标。它特别适用于对磁悬浮系统用电涡流传感器进行动态标定。
Patent CN-100572264-C (CN)
Title: 一种飞碟形纳米六方氮化硼粉末的制备方法
Inventor: XIAOLIANG SHI
IPC: C01B21/064
Filed: 2008-02-26
Granted: 2009-12-23
Abstract: 本发明属于一种飞碟形纳米六方氮化硼粉末的制备方法。本发明是将硼原料经过喷雾干燥后制备成硼前驱体粉末；球磨混合硼前驱体粉末和氮的化合物得到硼氮前驱体粉末；然后将硼氮前驱体混合粉末放入近似密闭的反应容器中，经过中温热处理后，得到无定形的氮化硼粉末；再将无定形的氮化硼粉末球磨处理，放在高温炉中，在氮气气氛下进行高温处理。将高温处理后得到的产物用蒸馏水洗涤，除去产物中可能存在的三氧化二硼等杂质，再经过无水乙醇的洗涤、干燥后，得到飞碟形纳米六方氮化硼粉末。本发明制备的飞碟形纳米六方氮化硼粉末具有粒度可调、纯度高、分散性好的特点，粉末的粒度控制在20nm～500nm。本发明工艺简捷、易控制、没有污染、投资成本低，适合于工业化规模生产。
Patent CA-2381507-E (CA)
Title: Poudre de fer extremement compressible
Inventor: OZAKI YUKIKO
IPC: C22C33/02
Filed: 2002-04-11
Granted: 2002-10-20
Abstract: Une poudre de fer extrêmement compressible pour la métallurgie des poudres comporte une distribution de tailles de particules optimisée. La microdureté Vickers des particules qui ne passent pas au travers du tamis ayant une ouverture nominale de 150 ?m est contrôlée pour être au plus environ 110. La poudre de fer est adaptée pour la production de pièces magnétiques ayant un magnétisme élevé et de pièces mécaniques ayant une haute résistance mécanique.
Patent PT-1020460-E (PT)
Title: The sodium salt of the (-)-enantiomer of omeprazole
Inventor: LINDBERG PER LENNART
IPC: A61P17/06
Filed: 1994-05-27
Abstract: The use of an alkaline salt of the (-)-enantiomer of omeprazole for the manufacture of a pharmaceutical preparation having improved pharmacokinetic and metabolic properties, such as improved therapeutic profile when treating gastric acid related diseases.
Patent PT-1163162-E (PT)
Inventor: TEPPE BRUNO
IPC: B65D47/28
Filed: 2000-03-09
Abstract: The closing device consisting of a sleeve that seals onto the neck of a bottle and that comprises an internal channel which opens, via a new orifice in a sliding-contact surface with associated slopes and slideways acting as guide means to a shut-off plate for closing the new orifice which is moved translationally by a knob, which sliding-contact surface may be planar or in the form of a sector of a cylinder of revolution or in the form of a portion of a sphere.
Patent PT-1190558-E (PT)
Title: Call sequence adaptation by analysing the history of previous communication sequences
Inventor: BOURGINE PAUL
IPC: H04M3/46
Filed: 2000-06-28
Abstract: A process for management of data transfer to a specific destination station having at least one real address including defining a virtual address of a destination station comprising an ordered sequence of real addresses of the destination station, sequentially searching through different addresses until obtaining a positive response establishing a communications channel, and transferring data to a multiplicity of telecommunications supports, and a communication device including telephonic communications transport means and data transfer means, means for storing in a memory calls issued and/or received by a party, means for storing in the memory addresses enabling connection of the party and means for sequential calling of a destination station from a list of addresses, and means for the storage in the memory of a history of past communication sequences and means for modeling optimal sequences for a multiplicity of telecommunications supports.
Patent PT-1196111-E (PT)
Inventor: CATERINI RICHARD
IPC: A61C8/00
Filed: 2000-07-12
Abstract: The invention concerns a dental implant made of a first metal, comprising an external coating layer (13) and a second porous metal. The first metal is a shape-memory titanium alloy, preferably a Ti-Ni, Ti-Ni-Co or Ti-Ni-Fe alloy. The second porous metal is titanium, a titanium alloy, preferably a Ti-Ni, Ti-Ni-Co or Ti-Ni-Fe alloy having 20 % to 50 % open porosity and pore dimensions of 50 to 400 microns. The invention is useful for producing a dental prosthesis.
Patent PT-1226267-E (PT)
Inventor: TOSSAVAINEN OLLI
IPC: A23L1/305
Filed: 2000-10-30
Abstract: The invention relates to a process for preparing a product containing antihypertensive peptides by fermenting a casein-containing starting material with lactic acid bacteria. The invention also relates to the obtained product and its use as a functional product as such or as an ingredient or additive of edible substances.
Patent PT-1240179-E (PT)
Inventor: PLATE RALF
IPC: C07J1/00
Filed: 2000-11-23
Abstract: The invention concerns a 3-methylene steroid derivative having general formula (1) wherein R1 is H or together with R3 forms a beta-epoxide or R1 is absent if there is a 5-10 or 4-5 double bond; R2 is (C1-C5) alkyl or CF3; R3 is betaH, betaCH3 or together with R1 forms a beta-epoxide or R3 is absent if there is a 5-10 double bond; R4 is H, lower alkyl; Y is [H, H], [OH, H], =O, [OH, lower alkyl], [OH, (C2-C5)alkenyl], [OH, (C2-C5)alkynyl] or (C1-C6) alkylidene, whereby said alkyl, alkenyl, alkynyl and alkylidene is optionally halogenated; =NOR5, whereby R5 is H, lower alkyl; dotted lines represent an optional double bond, or prodrugs thereof for the treatment of arthritic diseases and/or autoimmune diseases.
Patent PT-1116565-E (PT)
Inventor: BRAAK BART TER
IPC: B29C45/00
Filed: 2001-01-11
Abstract: A method for manufacturing at least one plastic curtain glider (201) comprising a body (206) and a substantially U-shaped eye (203,204,205) which has two legs (203,204) connected with the body (206) and an arch portion (205) connecting the legs (203,204) with each other at the ends remote from the body (206), the glider being manufactured by means of an injection molding process in an injection mold which is provided with at least one injection mold cavity (100) containing at least one glider cavity (101), the plastic being injected into the glider cavity (101) from such a position that plastic streams (A,B,C,D,E,F) formed in the glider cavity (101) during the injection do not meet each other in the arch portion (205) of the U-shaped eye (203,204,205). The invention also relates to an injection mold for use in the method and to a glider and glider strip obtained by means of the method, using the injection mold. <IMAGE>
Patent PT-1259487-E (PT)
Title: 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors
Inventor: BOLD GUIDO
IPC: A61K31/445
Filed: 2001-01-25
Abstract: The invention relates to the use of 2-amino-nicotinamide derivatives of formula I   
wherein n is from 1 up to and including 6; 
W is O or S; 
R 1  and R 3  represent independently of each other hydrogen, lower alkyl or lower acyl; 
R 2  represents a cycloalkyl group, an aryl group, or a mono- or bicyclic heteroaryl group comprising one or more ring nitrogen atoms and 0, 1 or 2 heteroatoms independently from each other selected from the group consisting of oxygen and sulfur, which groups in each case are unsubstituted or mono- or polysubstituted; 
R and R' are independently of each other hydrogen or lower alkyl; 
X represents an aryl group, or a mono- or bicyclic heteroaryl group comprising one or more ring nitrogen atoms and 0, 1 or 2 heteroatoms independently from each other selected from the group consisting of oxygen and sulfur, which groups in each case are unsubstituted or mono- or polysubstituted; 
or a N-oxide, a possible tautomer thereof or a pharmaceutically acceptable salt of such a compound, 
alone or in combination with one or more other pharmaceutically active compounds for the preparation of a pharmaceutical composition for use for therapy of a disease which responds to an inhibition of the VEGF-receptor tyrosine kinase activity; 
and to new 2-amino-nicotinamide derivatives of formula I and processes for the preparation thereof.
Patent PT-1335996-E (PT)
Title: Electrolytic cells with renewable electrode structures and method for substituting the same
Inventor: OLDANI DARIO
IPC: C25B15/00
Filed: 2001-10-30
Abstract: The invention is relative to an electrolytic cell comprising electrodes spaced apart from the back-wall by means of ribs, wherein a portion of the contact surface between the electrodes and the ribs is free from constraints in order to permit the complete removal of the electrodes once they have to be replaced by removing only partially the original contact surface, so that positioning of the substitute electrodes is allowed on the residual portion. A method for substituting the electrodes of the cell which leaves the distance between the electrode surface and the back-wall unvaried is also disclosed.
Patent PT-1409124-E (PT)
Inventor: JEE JACHUCK ROSHAN JEET
IPC: B01F25/74
Filed: 2002-07-22
Abstract: A method of manufacturing particles, especially nanoparticles, by way of precipitation from solution on a rotating surface (1) of a rotating surface reactor is disclosed. Nanoparticles with a tight size distribution may be manufactured in bulk and without the problems of agglomeration that are associated with traditional stirred-tank reactors. Use of a rotating surface reactor allows precipitation of nanoparticles from viscous, supersaturated solutions by way of homogeneous nucleation aided by strong micromixing.
Patent PT-1389102-E (PT)
Title: Use of lanthanum carbonate for the prevention of kidney stone disease
Inventor: ABRAMS MICHAEL J
IPC: A61K33/244
Filed: 2002-04-22
Abstract: A pharmaceutical composition comprises a salt of a rare earth metal (S1) and at least one nontoxic counterion (C1). (S1) Is optionally hydrated. ACTIVITY : Nephrotropic; Uropathic. MECHANISM OF ACTION : Oxalate Absorption Inhibitor. Stock sodium oxalate solution (50 ml) containing sodium chloride (8.5 g/l) was adjusted to either pH 3 or pH 7. Prior to the addition of lanthanum carbonate, a 2 ml sample was taken as a zero time point sample. The volume of buffer was made up to 50 ml, pH was adjusted and lanthanum carbonate was added so that a concentration of 0.1 M was present in the 50 ml of either pH 3 or pH 7 phosphate/oxalate buffer. A timer was started and 2 ml samples were removed at pre-determined time intervals over twenty minutes and analyzed. A phosphorus assay was performed as given in Sigma procedure 670. The results indicated that even in the presence of 10-fold excess phosphate, lanthanum carbonate bind oxalate.
Patent PT-1422975-E (PT)
Title: Light-emitting diode based product
Inventor: MORGAN FREDERICK M
IPC: H05B37/02
Filed: 2001-01-24
Abstract: A lighting device comprising: at least one LED; and a power converter coupled to the at least one LED and configured to provide DC power to the at least one LED, characterised in that the power converter is configured to receive power, from a dimming control, in the form of a variable amplitude AC signal or a chopped AC waveform, and convert the received power into DC power for the at least one LED.
Patent PT-1572087-E (PT)
Title: Antibodies against cancer antigen tmeff2 and uses thereof
Inventor: BHASKAR VINAY
IPC: A61K47/48
Filed: 2003-03-07
Abstract: The invention relates to the identification and generation of antibodies that bind to TMEFF2 proteins which are involved in cancer. Further, the invention provides for the use of these antibodies in the treatment of cancer.
Patent PT-1519885-E (PT)
Title: Conveyor belt
Inventor: PETROVIC ZMAJ
IPC: B65G17/08
Filed: 2003-07-02
Abstract: The planar conveyor belt is designed to move along curved trajectories and has a plurality of chain-links including, staggered at the fronts and at the rear of a central core, a succession of slots, each with an opening, in particular oblong in shape, so as to ensure play in a longitudinal direction of a chain-link relative to another adjacent chain-link. The conveyor belt is characterized in that at least on the side external to the curved trajectory it is designed to follow, at least some of the chain-links include, in their transverse extension, a chain-link modules providing, in particular across its slots a curvilinear contact zone with the pivot pins linking them.
Patent PT-1572725-E (PT)
Title: Chi-conotoxin peptides having a n-terminal pyroglutamic acid
Inventor: LEWIS RICHARD JAMES
IPC: A61P25/00
Filed: 2003-12-02
Abstract: An isolated, synthetic or recombinant χ-conotoxin peptide comprising the following sequence of amino acids: Xaa1 Xaa2 Gly Val Cys Cys Gly Tyr Lys Leu Cys His Pro Cys SEQ ID NO. 3 where Xaa1 is a N-terminal Xaa1 is a N-terminal pyroglutamate (pGlu) or D-pyroglutamate (DpGlu) residue; and Xaa2 is Asn or a deletion; or such a sequence in which one or more Cys is replaced with its corresponding D-amino acid and/or one or more amino acid residues other than Cys has undergone a side chain modification, or a salt, ester, amide or prodrug thereof. The invention also relates to pharmaceutical compositions comprising these peptides and the use of these peptides in the prophylaxis or treatment of conditions, such as but not limited to, pain, inflammation, incontinence, cardiovascular conditions and mood disorders.
Patent PT-1700069-E (PT)
Title: Refrigerator including an evaporator tray
Inventor: HEKIMOGLU AYDIN
IPC: F25D21/14
Filed: 2003-12-31
Abstract: By means of the evaporating tray (4) of the invention, defrost water is circulated to provide maximum contact with the heat by the duct (13) which is formed on the chambered middle chamber (8), therefore water is transferred to the hottest regions and the evaporation efficiency is increased by preventing the accumulation with the small chambers (5) (6) instead of large volume chambers (2) (3).
Patent PT-1468706-E (PT)
Title: Tamperproof retractable syringe
Inventor: SHAW THOMAS J
IPC: A61M5/178
Filed: 1996-04-24
Abstract: A tamperproof retractable syringe structure comprises a one piece hollow outer body (12) with an elongated barrel (14) and nose (16) and a plunger assembly (32) disposed partially within the barrel (14). A retraction mechanism (20) is sealingly disposed in the nose (16) with a retainer member (66a) surrounding a head (72a) of a needle holder (22a) as a further part of the retraction mechanism (20).  Such a retraction mechanism (20) can be disposed in a nose portion (16) of the syringe body (12) having retractable parts comprising the releasable needle holder (22a) and a needle (28) frictionally held by the wall of the syringe body (12). The retraction mechanism (20) includes a non-retractable part and according to the invention a reliable retractable tamperproof syringe with multiple tamperproof features is obtained which operates on the principle which permits low cost parts which are few in number and well suited for high-speed mass production and assembly.
Patent PT-1454673-E (PT)
Title: A device for crushing plastic products and/or semi-manufactured products in particular for the purpose of their recycling
Inventor: APPELTAUER JIRI
IPC: B02C4/08
Filed: 2004-02-16
Abstract: The invention relates to crushing products and/or semi-manufactured products from plastic material such as for example polypropylene comprising fiberglass or another armoring fiber or from a non-armored plastic material e.g. PET bottles. In the supporting frame of the crushing device (1) there are in a shared space a first crushing section (11) consisting of a pair of parallel crush rolls (111,112) fitted with teeth, a second crushing section (12) consisting of a pair of parallel crush rolls (121,122) fitted with teeth and a feed hopper (15) with a crushed material conveyor (16) positioned below each other and the axes of crush rolls (121,122) of the second crushing section (12) are in the floor projection positioned approximately perpendicularly to the axes of crush rolls (111,112) of the first crushing section (11) and the shared space is through a filtering device (19) interconnected with a vacuum source. <IMAGE>
Patent PT-1651213-E (PT)
Title: Use of angiotensin ii receptor antagonists, especially telmisartan, in order to increase insulin sensitivity
Inventor: MARK MICHAEL
IPC: A61K45/00
Filed: 2004-07-24
Abstract: Angiotensin II receptor antagonist is used to prepare a medicament for treating people for whom type 2 diabetes has been diagnosed or prediabetes is suspected, for preventing diabetes or for treating metabolic syndrome and insulin resistance in patients with normal blood pressure. An independent claim is also included for a composition comprising telmisartan in combination with: amlodipine or nifedipine; eplerenone or spironolactone; simvastatin or atorvastatin; rosiglitazone, pioglitazone, repaglinide or metformin; dipyridamol or clopidogrel, optionally in combination with aspirin; an aldosterone antagonist; a HMG-CoA reductase inhibitor; a dipeptidyl peptidase 4 inhibitor; a sulfonylurea; or a thrombocyte aggregation inhibitor. ACTIVITY : Antidiabetic. MECHANISM OF ACTION : Angiotensin II Receptor Antagonist; Peroxisomal Proliferator Activated Receptor Gamma (PPARgamma) Activator. PC12W cells overexpressing PPARgamma 2 and its heterodimer partner RXRalpha were treated with telmisartan (10 MicroM). PPARgamma activity was increased by a factor of 1.9.
Patent PT-1728445-E (PT)
Title: Self-ventilated, ergonomic footwear and sole
IPC: A43B13/12
Filed: 2005-01-14
Abstract: The invention relates to a self-ventilated, ergonomic footwear item and elastomeric sole. According to the invention, both sides of the sole comprise a plurality of longitudinal grooves, in the area corresponding to the sole of the foot, which are essentially parallel to the edge of the sole closest thereto and which have a depth equal to half of the height of the sole. Moreover, the grooves are disposed in an alternating manner in relation to one another on either side of the sole in the form of a bellows-type structure. The upper comprises a perforated elastic laminar body which is disposed beneath the insole in the area corresponding to the sole and the foot and which, together with the sole, forms a chamber having a volume that varies upon walking. In addition, three thick bands are solidly connected to the body and the upper in order to stiffen said elastic laminar body, namely: one longitudinal band and two transverse end bands. In this way the footwear item and the sole adapt perfectly to the anatomy of the foot, enabling same to be automatically ventilated upon walking.
Patent PT-1782802-E (PT)
Title: Combined use of pterostilbene and quercetin for the production of cancer treatment medicaments
Inventor: ARIQUEL JOSE M ESTRELA
IPC: A61K31/09
Filed: 2005-07-19
Abstract: The invention relates to the combined use of pterostilbene and quercetin for the production of cancer treatment medicaments. The  in vitro  growth of melanoma cells B16-F10 (B1611-F10) is inhibited (56%) by combined exposures of short duration (60 min/day) to PTER (40 µM) + QUER (20 µM) (- average values of plasma concentrations measured within the first hour following the IV administration of 20 mg of each polyphenol/kg -). The combined intravenous administration of PTER + QUER (20 mg/kg x day) to mice inhibits (73%) the metastatic growth of melanoma B16M-F10 in the liver, a common site for metastasis development. The invention demonstrates that the combination of PTER + QUER inhibits the growth of malignant melanoma metastasis and prolongs the survival of the carrier host.
Patent PT-1831524-E (PT)
Title: Method for determining fuel volatility and consequently performing cold starting of an internal combustion engine
Inventor: MAZET HENRI
IPC: F02D41/06
Filed: 2005-12-21
Abstract: A method for determining fuel volatility and consequently performing cold starting of an internal combustion engine; in the event of cold starting, the method provides for the determination of an enrichment percentage as a function of a stored value for fuel volatility; the determination of a predicted value for starting quality before performing starting; the starting of the engine using the previously determined enrichment percentage; the determination of a measured value for starting quality; the determination of a correction value of the stored value for fuel volatility as a function of the comparison between the measured value for starting quality and the predicted value for starting quality; and the updating of the stored value for fuel volatility by applying the correction value to said stored value, so consequently modifying the amount of enrichment in force.
Patent PT-1846406-E (PT)
Title: Maleimide derivatives, pharmaceutical compositions and methods for treatment of cancer
Inventor: LI CHIANG J
IPC: A61K38/08
Filed: 2006-02-09
Abstract: The present invention relates to pyrroloquinolinyl-pyrrole-2,5-dione compounds and pyrroloquinolinyl-pyrrolidine-2,5-dione compounds, and methods of preparation of these compounds. The present invention also relates to pharmaceutical compositions comprising pyrroloquinolinyl-pyrrole-2,5-dione compounds and pyrroloquinolinyl-pyrrolidine-2,5-dione compounds. The present invention provides methods of treating a cell proliferative disorder, such as a cancer, by administering to a subject in need thereof a therapeutically effective amount of a pyrroloquinolinyl-pyrrole-2,5-dione compound or pyrroloquinolinyl-pyrrolidine-2,5-dione compound of the present invention.